We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Metacognitive Therapy for Comorbid Insomnia

This study has been withdrawn prior to enrollment.
(problems recruiting patients)
Sponsor:
ClinicalTrials.gov Identifier:
NCT00235365
First Posted: October 10, 2005
Last Update Posted: November 22, 2012
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by (Responsible Party):
Norwegian University of Science and Technology
  Purpose
The purpose of this study is to determine the effect of meta-cognitive therapy for insomnia.

Condition Intervention
Secondary Insomnia Behavioral: meta-cognitive therapy Other: waiting list

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
Official Title: Metacognitive Therapy for Patients With a Psychiatric Disorder and Comorbid Insomnia.

Further study details as provided by Norwegian University of Science and Technology:

Primary Outcome Measures:
  • Scores on rating scales for sleep quality [ Time Frame: one year ]

Secondary Outcome Measures:
  • Scores on rating scales for depression, psychiatric symptom severity, and cognitive processing. [ Time Frame: one year ]

Enrollment: 0
Study Start Date: August 2009
Study Completion Date: January 2011
Primary Completion Date: January 2011 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: meta-cognitive therapy
meta-cognitive therapy
Behavioral: meta-cognitive therapy
Meta-cognitive therapy
Active Comparator: waiting list
waiting list control
Other: waiting list
waiting list control

Detailed Description:
This study is a randomized controlled trial with 50 patients with a psychiatric disorder and insomnia. The patients will be randomized into two groups of 25 patients. The first group receives meta-cognitive therapy, whereas the second group will be assigned to a waiting list control.
  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • Insomnia secondary to a primary psychiatric disorder

Exclusion Criteria:

  • substance abuse, psychotic symptoms, suicidal intentions, severe organic disorder or psychiatric disorder where sleep restriction is not advised, organic sleep disorder.
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00235365


Sponsors and Collaborators
Norwegian University of Science and Technology
Investigators
Principal Investigator: Gunnar Morken, PhD MD Norwegian University of Science and Technology
  More Information

Responsible Party: Norwegian University of Science and Technology
ClinicalTrials.gov Identifier: NCT00235365     History of Changes
Other Study ID Numbers: S2005.2.gr
First Submitted: October 7, 2005
First Posted: October 10, 2005
Last Update Posted: November 22, 2012
Last Verified: November 2012

Additional relevant MeSH terms:
Sleep Initiation and Maintenance Disorders
Sleep Disorders, Intrinsic
Dyssomnias
Sleep Wake Disorders
Nervous System Diseases
Mental Disorders